Curcumin improves glucose tolerance via stimulation of glucagon-like peptide-1 secretion

Molecular Nutrition and Food Research

Volumn 61, Issue 3, 2017, Pages

  Kato, Masaki ^a   Nishikawa, Sho ^a   Ikehata, Akiho ^a   Dochi, Kojiro ^a   Tani, Tsubasa ^a   Takahashi, Tsukasa ^b   Imaizumi, Atsushi ^b   Tsuda, Takanori ^a  

^a CHUBU UNIVERSITY   (Japan)

^b Theravalues Corporation   (Japan)

Author keywords

Curcumin; Diabetes; G protein coupled receptor 40 120; Glucagon like peptide 1; Glucose tolerance

Indexed keywords

BENZOIC ACID DERIVATIVE; CURCUMIN; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GPR40 PROTEIN, MOUSE; GW1100; INSULIN; O3FAR1 PROTEIN, MOUSE; PYRIMIDINE DERIVATIVE;

ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CELL LINE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; SECRETION (PROCESS); SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; BENZOATES; BLOOD GLUCOSE; CELL LINE; CURCUMIN; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIA; INJECTIONS, INTRAPERITONEAL; INSULIN; MALE; MICE; PYRIMIDINES; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85007195734     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600471     Document Type: Article

References (20)

1. Pulido-Moran, M., JMoreno-Fernandez, J., Ramirez-Tortosa, C., Ramirez-Tortosa, M., Curcumin and health. Molecules 2016, 21, 264; doi: 10.3390/molecules21030264.
2. Chuengsamarn, S., Rattanamongkolgul, S., Luechapudiporn, R., Phisalaphong, C. et al., Curcumin extract for prevention of type 2 diabetes. Diabet. Care 2012, 35, 2121–2127.
3. Mojsov, S., Weir, G. C., Habener, J. F., Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 1987, 79, 616–619.
4. Kreymann, B., Williams, G., Ghatei, M. A., Bloom, S. R., Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987, 2, 1300–1304.
5. Buteau, J., Foisy, S., Joly, E., Prentki, M., Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 2003, 52, 124–132.
6. Vilsbøll, T., Brock, B., Perrild, H., Levin, K. et al., Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus. Diabet. Med. 2008, 25, 152–156.
7. Herman, G. A., Bergman, A., Stevens, C., Kotey, P. et al., Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 2006, 91, 4612–4619.
8. Tsuda, T., Possible abilities of dietary factors to prevent and treat diabetes via the stimulation of glucagon-like peptide-1 secretion. Mol. Nutr. Food Res. 2015, 59, 1264–1273.
9. 2+/calmodulin-dependent kinase II activation. Biochem. Biophys. Res. Commun. 2013, 435, 165–170.
10. Sasaki, H., Sunagawa, Y., Takahashi, K., Imaizumi, A. et al., Innovative preparation of curcumin for improved oral bioavailability. Biol. Pharm. Bull. 2011, 34, 660–665.
11. Nagamine, R., Ueno, S., Tsubata, M., Yamaguchi, K. et al., Dietary sweet potato (Ipomoea batatas L.) leaf extract attenuates hyperglycaemia by enhancing the secretion of glucagon-like peptide-1 (GLP-1). Food Funct. 2014, 5, 2309–2319.
12. Drucker, D. J., Jin, T., Asa, S. L., Young, T. A. et al., Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Mol. Endocrinol. 1994, 8, 1646–1655.
13. Kato, M., Tani, T., Terahara, N., Tsuda, T., The Anthocyanin delphinidin 3-rutinoside stimulates glucagon-like peptide-1 secretion in murine GLUTag cell line via the Ca2+/calmodulin-dependent kinase II pathway. PLoS One 2015, 10, e0126157.
14. Janssen, S., Depoortere, I., Nutrient sensing in the gut: new roads to therapeutics? Trends Endocrinol. Metab. 2013, 24, 92–100.
15. Edfalk, S., Steneberg, P., Edlund, H., Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 2008, 7, 2280–2287.
16. Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S. et al., Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 2005, 11, 90–94.
17. Subash, C. G., Patchva, S., Koh, W., B., Aggarwal, B. B., Discovery of curcumin, a component of the golden spice, and its miraculous biological activities. Clin. Exp. Pharmacol Physiol. 2012, 39, 283–299.
18. Subash, C. G., Patchva, S., Aggarwal, B. B., Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013, 15, 195–218.
19. Yang, K. Y., Lin, L. C., Tseng, T. Y., Wang, S. C. et al., Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J. Chromatogr. B 2007, 853, 183–189.
20. Imaizumi, A., Highly bioavailable curcumin (Theracurmin): its development and clinical application. PharmaNutr. 2015, 3, 123–130.